Guardant Health Files Q2 2024 10-Q
Ticker: GH · Form: 10-Q · Filed: 2024-08-07T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, earnings, healthcare, diagnostics
TL;DR
Guardant Health's Q2 2024 10-Q is in. Check financials.
AI Summary
Guardant Health, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of 2024. Key financial data and business segments are presented, reflecting the company's ongoing activities in the medical laboratory services sector.
Why It Matters
This filing provides investors and analysts with the latest financial results and operational details for Guardant Health, crucial for understanding the company's performance in the competitive oncology diagnostics market.
Risk Assessment
Risk Level: medium — As a publicly traded company in the healthcare sector, Guardant Health faces inherent risks related to regulatory changes, competition, and market adoption of its diagnostic technologies.
Key Numbers
- 2024 Q2 — Reporting Period (Indicates the specific quarter for which financial information is provided.)
- 12-31 — Fiscal Year End (Specifies the end date of the company's fiscal year.)
Key Players & Entities
- Guardant Health, Inc. (company) — Filer of the 10-Q
- 20240630 (date) — End of the reporting period
- 20240807 (date) — Filing date
- PALO ALTO, CA (location) — Company headquarters
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended June 30, 2024 (20240630).
When was this 10-Q filed with the SEC?
This 10-Q was filed on August 7, 2024 (20240807).
What is the primary business of Guardant Health, Inc. according to the SIC code?
Guardant Health, Inc. is classified under SIC code 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.
Where is Guardant Health, Inc. headquartered?
Guardant Health, Inc. is headquartered at 3100 Hanover Street, Palo Alto, CA 94304.
What is the SEC file number for Guardant Health, Inc.?
The SEC file number for Guardant Health, Inc. is 001-38683.
From the Filing
0001576280-24-000190.txt : 20240807 0001576280-24-000190.hdr.sgml : 20240807 20240807171253 ACCESSION NUMBER: 0001576280-24-000190 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 87 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240807 DATE AS OF CHANGE: 20240807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 241184971 BUSINESS ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 10-Q 1 gh-20240630.htm 10-Q gh-20240630 false 2024 Q2 0001576280 12-31 0.0071523 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure gh:segment gh:trading_day gh:patent gh:tranche 0001576280 2024-01-01 2024-06-30 0001576280 2024-08-02 0001576280 2024-06-30 0001576280 2023-12-31 0001576280 2024-04-01 2024-06-30 0001576280 2023-04-01 2023-06-30 0001576280 2023-01-01 2023-06-30 0001576280 us-gaap:CommonStockMember 2024-03-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001576280 us-gaap:RetainedEarningsMember 2024-03-31 0001576280 2024-03-31 0001576280 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001576280 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001576280 us-gaap:CommonStockMember 2024-06-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001576280 us-gaap:RetainedEarningsMember 2024-06-30 0001576280 us-gaap:CommonStockMember 2023-03-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001576280 us-gaap:RetainedEarningsMember 2023-03-31 0001576280 2023-03-31 0001576280 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001576280 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001576280 us-gaap:CommonStockMember 2023-06-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001576280 us-gaap:RetainedEarningsMember 2023-06-30 0001576280 2023-06-30 0001576280 us-gaap:CommonStockMember 2023-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001576280 us-gaap:RetainedEarningsMember 2023-12-31 0001576280 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-06-30 0001576280 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0001576280 us-gaap:CommonStockMember 2022-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001576280 us-gaap:RetainedEarningsMember 2022-12-31 0001576280 2022-12-31 0001576280 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001576280 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001576280 2022-01-01 2022-12-31 0001576280 2023-06-01 2023-06-30 0001576280 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMemb